Evidence map›Paper›PMID 40875031›Full record

ArticleArchives of microbiology2025

DNA gyrase-inhibitory antimicrobial anthraquinone from the endophytic Sordariomycetes fungus Diaporthe perseae.

Joe Anthony H Manzano, John Cyril D Abanto, Beaver Andrei F Dayo, Lloyd Christian J Llames, Mary Grace E Gonzaga, Simone Brogi, Allan Patrick G Macabeo

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Novel Metabolites ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joe Anthony H ManzanoDepartment of Biological Sciences, College of Science, and UST Laboratories for Vaccine Science, Molecular Biology, and Biotechnology, University of Santo Tomas, España Blvd., Manila, 1015, Philippines. jhmanzano@ust.edu.ph.ORCID https://orcid.org/0000-0002-4062-223X
John Cyril D AbantoDepartment of Chemistry, College of Science, University of Santo Tomas, España Blvd., Manila, 1015, Philippines.ORCID https://orcid.org/0009-0004-2794-0040
Beaver Andrei F DayoDepartment of Chemistry, College of Science, University of Santo Tomas, España Blvd., Manila, 1015, Philippines.ORCID https://orcid.org/0000-0002-8067-6064
Lloyd Christian J LlamesResearch Center for the Natural and Applied Sciences, University of Santo Tomas, España Blvd., Manila, 1015, Philippines.ORCID https://orcid.org/0000-0001-9105-9558
Mary Grace E GonzagaCollege of Arts and Sciences, President Ramon Magsaysay State University, Iba, 2201, Zambales, Philippines.
Simone BrogiDepartment of Pharmacy, University of Pisa, Via Bonanno 6, Pisa, 56126, Italy.ORCID http://orcid.org/0000-0001-9375-6242
Allan Patrick G MacabeoDepartment of Microbial Drugs, Helmholtz Center for Infection Research, Braunschweig, Inhoffenstrasse 7, 38124, Braunschweig, Germany. allanpatrick.macabeo78@gmail.com.ORCID https://orcid.org/0000-0001-7972-106X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungi of the order Diaporthales are prolific sources of antimicrobial secondary metabolites. In this paper, we describe antimicrobial and antituberculosis anthraquinones (AQs) from Diaporthe perseae, an endophytic fungus isolated and identified from the endemic Philippine medicinal plant Uvaria alba (Annonaceae). Large-scale rice fermentation of D. perseae yielded an ethyl acetate extract which was subjected to a series of chromatographic purification to yield three compounds. Spectroscopic analyses allowed the identification of the anthraquinone compounds citreorosein (1), skyrin (2), and rugulosin A (3). AQs 1 and 3 showed broad-spectrum against Gram-positive bacteria (Micrococcus luteus, Bacillus subtilis, and Staphylococcus aureus) (MIC = 1.0-2.0 µg/mL), however only 3 demonstrated strong inhibition against Gram-negative bacterial strains (Escherichia coli, Pseudomonas aeruginosa, and Chromobacterium violaceum) and non-TB mycobacteria (Mycobacterium smegmatis) (MIC = 8.25-66.0 µg/mL). AQ 3 also exhibited inhibition against both M. tuberculosis (Mtb) H

Indexed as

AnthraquinonesAnti-Bacterial AgentsAscomycotaDNA GyraseTopoisomerase II InhibitorsEndophytesGram-Negative BacteriaGram-Positive BacteriaMicrobial Sensitivity TestsMolecular Docking SimulationMycobacterium smegmatisAnthraquinonesAnti-Bacterial AgentsDNA GyraseTopoisomerase II InhibitorsAnthraquinonesDiaporthe perseaeMolecular docking and dynamicsRugulosin A, tuberculosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.